It has been reported that the ablation of ALCAT1, an acyltransferase that catalyzes the pathological remodeling of CL, significantly improves mitophagy in PD by promoting the recruitment of Parkin to dysfunctional mitochondria (Song et al., 2019). Here, LCLAT1 is linked to Parkinson disease.